menu search

New strong sell stocks for march 27th

ASMIY, abst and ASLE have been added to the Zacks Rank #5 (Strong Sell) List on March 27, 2023....

March 27, 2023, 8:25 am

Eisai to present research from oncology portfolio at the society of gynecologic oncology (sgo) 2023 annual meeting on women's cancer

Study Findings in Patients with Recurrent or Advanced Endometrial Carcinoma Who Were Rechallenged With Platinum Chemotherapy Will Be Featured in an Or...

March 23, 2023, 8:08 am

Biogen als drug considered not effective by fda advisory panel

Biogen Inc. BIIB, -1.85% received a setback late Wednesday after a Food and Drug Administration advisory committee said the biotech drug maker's propo...

March 22, 2023, 6:27 pm

Edesa biotech to present favorable dermatitis drug results at american academy of dermatology association annual meeting

TORONTO, ON / ACCESSWIRE / March 16, 2023 / Edesa Biotech, Inc. announced today that the company has been selected to present clinical trial data from...

March 16, 2023, 4:10 pm

Celcuity to present preclinical data on therapeutic effects of gedatolisib in gynecological cancer models at aacr annual meeting 2023

MINNEAPOLIS, MN / ACCESSWIRE / March 15, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted...

March 15, 2023, 7:35 pm

Context therapeutics says ctim-76 abstract accepted for presentation at aacr annual meeting

Context Therapeutics (NASDAQ:CNTX) Inc announced that an abstract regarding its preclinical candidate, CTIM-76, a Claudin 6 x CD3 bispecific antibody,...

March 15, 2023, 9:16 am

Kinnate biopharma inc. to report first clinical data for its investigational pan-raf inhibitor, exarafenib (kin-2787), in an oral presentation at the aacr 2023 annual meeting

SAN FRANCISCO and SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision onco...

March 14, 2023, 6:09 pm

Windtree announces istaroxime scientific abstract has been accepted at the 2023 technology and heart failure therapeutics conference

WARRINGTON, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnolog...

February 27, 2023, 1:00 pm

Genprex unveils groundbreaking data from primate study on its novel gene therapy to treat type 1 diabetes at attd 2023 in berlin

Genprex, Inc. (NASDAQ:GNPX) has announced that data highlighting the potential of its gene therapy for Type 1 diabetes is being presented by its resea...

February 23, 2023, 8:40 am

Apple may soon launch a foldable device which ‘could be an incremental opportunity'

Apple Inc (NASDAQ: AAPL) is trading up this morning on speculation that it may soon launch a long-rumoured folding iPhone or iPad. UBS analyst reacts ...

February 15, 2023, 4:22 pm

Absolute software corporation (abst) q2 2023 earnings call transcript

Absolute Software Corporation (NASDAQ:abst ) Q2 2023 Earnings Conference Call February 14, 2023 5:00 PM...

February 14, 2023, 9:46 pm

Absolute software corporation (abst) reports q2 loss, lags revenue estimates

Absolute Software Corporation (ABST) delivered earnings and revenue surprises of -244.44% and 4.52%, respectively, for the quarter ended December 2022...

February 14, 2023, 7:34 pm

Hyperfine swoop® point-of-care mri system™ takes the stage at ismrm with twelve abstract inclusions

Research highlights the significance and clinical relevance of portable MRI technology GUILFORD, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) — Hyperfine, ...

February 6, 2023, 11:31 pm

Pulmatrix to present data on pur1800 at the annual meeting of the american academy of allergy, asthma and immunology

LEXINGTON, Mass. , Jan. 23, 2023 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inha...

January 23, 2023, 9:05 am

Absolute software declares cad 0.08 dividend

Absolute Software (NASDAQ:ABST) declares CAD 0.08/share quarterly dividend, in line with previous. Forward yield 2.09% Payable Feb. 23; for shareholde...

January 18, 2023, 10:44 pm

Guaranty bancshares, inc. (gnty) q4 2022 earnings call transcript

Guaranty Bancshares, Inc. (NASDAQ:GNTY ) Q4 2022 Earnings Conference Call January 17, 2023 11:00 AM ET Company Participants Ty Abston - Chairman & CEO...

January 17, 2023, 1:37 pm

Absolute software to present at needham growth conference

VANCOUVER, British Columbia & SAN JOSE, Calif.--( BUSINESS WIRE )--Absolute Software™ (NASDAQ: ABST) (TSX: ABST), the only provider of self-healing,...

January 5, 2023, 4:20 pm

Asos facing investor rebellion over former bosses salary

ASOS PLC (LSE:ASC) is expecting an investor rebellion after stand-in boss Mat Dunn pocketed a salary of £576,000 last year, according to reports. Acc...

December 29, 2022, 7:37 am

Adaptive biotechnologies highlights new data showcasing the clinical utility of clonoseq® mrd testing in patients with blood cancers at the 64th ash annual meeting

Multiple presentations reinforce clonoSEQ’s ability to provide valuable insights for treatment surveillance and clinical decision-making More than 3...

December 10, 2022, 3:00 pm

New strong sell stocks for december 7th

ABST, AMYT and ARCE have been added to the Zacks Rank #5 (Strong Sell) List on December 7, 2022....

December 7, 2022, 8:17 am


Search within

Pages Search Results: